CAPN3 p.Arg541Trp
c.1621C>T · rs142004418 · VCV498267
ClinGen expert panel — Limb Girdle Muscular Dystrophy VCEP
Pathogenic for autosomal recessive limb-girdle muscular dystrophy. Applied ACMG criteria (verbatim):
PM2_Supporting PM3_VeryStrong PP1_Moderate PP3 PP4
Curation rationale (ClinGen, verbatim)
The NM_000070.3: c.1621C>T variant in CAPN3 is a missense variant predicted to cause the substitution of tryptophan for arginine at position 541, p.(Arg541Trp). Across a selection of the available literature, this variant has been reported in at least 11 unrelated patients with features of LGMD (PMID: 19556129, 18854869, 32576226, 30919934, 25214167, 16100770, 36575883, 31066050), including in a homozygous state in two unrelated probands without reported consanguinity (0.5 pts x2; PMID: 31066050, 30919934), confirmed in trans with a pathogenic variant in three probands (c.701G>A p.(Gly234Glu), 1.0 pt, PMID: 3657588; c.550del p.(Thr184ArgfsTer36), 1.0 pt, PMID: 16100770; c.598_612del p.(Phe200_Leu204del), 1.0 pt, PMID: 16100770), and in unconfirmed phase with a pathogenic variant in two probands (c.550del p.(Thr184ArgfsTer36), 0.5 pts, PMID: 16100770; c.598_612del p.(Phe200_Leu204del), 0.5 pts, PMID: 18854869) (PM3_Very Strong). At least one patient with this variant and a second presumed diagnostic CAPN3 allele displayed progressive limb girdle muscle weakness (PP4). In addition, two affected family members of a homozygous proband were also shown to be homozygous for this variant (PMID: 30919934; PP1_Moderate). The highest population variant allele frequency in gnomAD v4.1.0 for is 0.00004455 (2/44898 East Asian chromosomes), which is is lower than the LGMD VCEP threshold (<0.0001) for PM2_Supporting, meeting this criterion (PM2_Supporting). The computational predictor REVEL gives a score of 0.896, which is above the LGMD VCEP threshold of ≥0.70, evidence that correlates with impact to CAPN3 function. In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 2.0.0; 12/29/2025): PM3_Very Strong, PP4, PP1_Moderate, PM2_Supporting, PP3.
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9844 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.896 | moderately pathogenic-leaning |
| SaProt | LLR -14.31 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 2.6 | GERP 2.8, phastCons 1 |
| Regional constraint | o/e 0.96 | unconstrained · MANE · 52 kb · p 0.21 · regional, not allelic |
| Overall | ||
| CADD | 33.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.00445% | 22,449 |
| Remaining individualsnot grpmax-eligible | 0.0032% | 31,244 |
| South Asian | 0.0022% | 45,541 |
| European (non-Finnish) | 0.00186% | 53,635 |
| Admixed American | 0.00167% | 60,000 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CAPN3
- Protein
- p.Arg541Trp
- Coding
- c.1621C>T
- MANE Select
- NM_000070
- dbSNP
- rs142004418
- Type
- single nucleotide variant
- Location
- chr15:42402878 (GRCh38)
- Gene constraint
- LOEUF 0.896 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 79.18 · 5 PDB
- Residue 541
- the 'domain iii' region; a UniProt-annotated variant site (in lgmdr1)
Disease context
autosomal recessive limb-girdle muscular dystrophy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: type 2 diabetes mellitusautosomal recessive limb-girdle muscular dystrophy type 2Amuscular dystrophy, limb-girdle, autosomal dominant 4
Similar variants
- CAPN3 p.Arg541Gln Pathogenic ★★★ same residue
- CAPN3 p.Arg541Gly Conflicting classifications of pathogenicity ★ ⚠ same residue
- CAPN3 p.Arg541Pro Likely pathogenic ★ same residue
- CAPN3 c.1115+5G>C Pathogenic ★★★ same condition
- CAPN3 c.1194-2A>G Pathogenic ★★★ same condition
- CAPN3 c.1194-9A>G Pathogenic ★★★ same condition
- CAPN3 c.1746-20C>G Pathogenic ★★★ same condition
- CAPN3 c.1993-1G>A Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/capn3-p-arg541trp (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown